Legal Opinion
Pfizer Inc. v. Apotex Inc.
District Court, N.D. Illinois
Decided June 30, 2010No. Case Nos.: 08-cv-7231, 09-cv-6053PublishedCited by 11 opinions
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
ROBERT M. DOW, JR., District Judge.
Plaintiffs Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, Warner-Lambert Company LLC (collectively “Pfizer”) filed this patent infringement action against Defendants Apotex Inc. and Apotex Corp. (collectively “Apotex”) for infringement of United States Patent No. 5,273,995 (“the '995 patent”). After Pfizer filed its initial complaint, the '995 patent was reissued in part as U.S. Patent No. 40,667 (“the '667 patent”). Pfizer has since amended its complaint to include a claim for infringement of the '667 patent.
2Cases cited34 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Conley v. GibsonSupreme Court of the United States · 1957
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
29 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Tyco Fire Products LP v. Victaulic Co.District Court, E.D. Pennsylvania · 2011
- Senju Pharmaceutical Co. v. Apotex, Inc.District Court, D. Delaware · 2013
- Fujitsu Ltd. v. Belkin International, Inc.District Court, N.D. California · 2011
- Microsoft Corp. v. Phoenix Solutions, Inc.District Court, C.D. California · 2010
- Pfizer Inc. v. Apotex Inc.District Court, N.D. Illinois · 2010
6 more not listed; retrieve them via the Exa API.